Consortia to Advance Collaboration in Epidemiologic and Cancer Research
On this page...
![](https://webarchive.library.unt.edu/web/20201218005147im_/https://epi.grants.cancer.gov/i/consortia.jpg)
EGRP's Definition of Consortia
The National Cancer Institute's (NCI) Epidemiology and Genomics Research Program (EGRP) defines a consortium as a group of scientists from multiple institutions who have agreed to participate in cooperative research efforts involving activities such as methods development and validation, pooling of information from more than one study for the purpose of combined analyses, and collaborative projects. Consortia are able to address scientific questions that cannot be addressed otherwise due to scope, resources, population size, or expertise. This cooperation usually involves multiple projects over an extended period of time. Consortia can also be referred to as collaboratives.
The creation of a consortium is independent from NCI and NIH funding mechanisms. Groups participating in a consortium may partner in the writing of research grant applications, but consortium activities are not limited to a specific grant/project.
For sources of support, view our compilation of NCI and NIH funding opportunities that are relevant to cancer epidemiology or contact an EGRP Program Director.
NCI Cohort Consortium
![](https://webarchive.library.unt.edu/web/20201218005147im_/https://epi.grants.cancer.gov/i/consortia/banner-cohort.jpg)
- Foster communication among investigators leading cohort studies of cancer;
- Promote collaborative research projects for topics not easily addressed in a single study; and
- Identify common challenges in cohort research and search for solutions.
The NCI Cohort Consortium is an extramural-intramural partnership formed by NCI to address the need for large-scale collaborations to pool the large quantity of data and biospecimens necessary to conduct a wide range of cancer studies. The Consortium, through its collaborative network of investigators, provides a coordinated, interdisciplinary approach to tackling important scientific questions, economies of scale, and opportunities to quicken the pace of research.
The NCI Cohort Consortium includes investigators responsible for more than 50 high-quality cohorts involving more than 7 million people. The cohorts are international in scope and cover large, rich, and diverse populations. Extensive risk factor data are available on each cohort, and biospecimens including germline DNA collected at baseline, are available on approximately 2 million individuals. Investigators team up to use common protocols and methods, and to conduct coordinated parallel and pooled analyses.
Cancer Epidemiology Consortia
The list below provides links to information about research consortia that may be of interest to cancer epidemiologists. It is not an exhaustive list. Access to resources is dependent on procedures outlined for each individual consortium. Consortia interested in being included in this list should contact NCIEpiConsortia@mail.nih.gov.
Bladder Cancer
-
International Consortium of Bladder Cancer (ICBC)
Since 2005
NIH Contacts
EGRP/NCI:
ICBC Liaison:
Gabriel Lai, Ph.D.DCEG/NCI:
Montserrat Garcia-Closas, M.D., Dr.P.H.Lead Investigator:
Xifeng Wu, M.D., Ph.D.
The University of Texas M. D. Anderson Cancer Center
Brain Cancer
-
Brain Tumor Epidemiology Consortium (BTEC)
Since 2003
NIH Contacts
EGRP/NCI:
BTEC Liaison:
Melissa Rotunno, Ph.D.DCEG/NCI:
Preetha Rajaraman, Ph.D.Lead Investigators:
Luc Bauchet, M.D., Ph.D.
Centre Hospitalo-Universitaire (CHU) and National Institute of Health and Medical Research (INSERM), Montpellier, FranceJoe Wiemels, Ph.D.
University of California, San Francisco -
GLIOGENE
Since 2007
NIH Contacts
EGRP/NCI:
GLIOGENE Liaison:
Melissa Rotunno, Ph.D.Lead Investigator:
Melissa Bondy, Ph.D.
Baylor College of Medicine -
Pediatric Brain Tumor Consortium (PBTC)
Since 1999
NIH Contacts
EGRP/NCI:
PBTC Liaison:
Mukesh Verma, Ph.D.DCEG/NCI:
Peter Inskip, Sc.D.Lead Investigator:
Includes various EGRP-funded investigators teamed with DCEG investigators.
Patricia Buffler, Ph.D, M.P.H.
University of California, Berkeley
Breast Cancer
-
African-American Breast Cancer Consortium
Since 2008
NIH Contacts
EGRP/NCI:
Consortium Liaison:
Stefanie A. Nelson, Ph.D.Lead Investigators:
Chris Haiman, Ph.D.
Norris Comprehensive Cancer Center,
University of Southern CaliforniaFunmi Olopade, M.D.
The University of ChicagoJulie Palmer, Sc.D.
Boston University -
Asian Breast Cancer Consortium (ABCC)
Since 2008
NIH Contacts
EGRP/NCI:
ABCC Liaison:
Gabriel Lai, Ph.D.Lead Investigator:
Wei Zheng, M.D., Ph.D.
Vanderbilt University School of Medicine
University of Southern California -
Breast Cancer Association Consortium (BCAC)
Since 2005
NIH Contacts
EGRP/NCI:
BCAC Liaison:
Lisa Gallicchio, Ph.D.
Stefanie Nelson, Ph.D.Lead Investigators:
Douglas Easton, Ph.D.
University of CambridgePaul Pharoah, Ph.D.
Cambridge Cancer CenterGeorgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical ResearchManjeet Humphreys
University of Cambridge -
Breast Cancer Consortium for Outcomes And Survival (BC2OS)
-
Breast Cancer Family Registry (B-CFR)Visit Consortium Website
Since 1995
NIH Contacts
EGRP/NCI:
B-CFR Liaison:
Scott Rogers, M.P.H. (for Informatics)Lead Investigators:
Irene Andrulis, Ph.D.
Cancer Care OntarioSaundra Buys, M.D.
University of Utah Health Sciences CenterMary Daly, M.D., Ph.D.
Fox Chase Cancer CenterJohn Hopper, Ph.D.
University of MelbourneEsther John, Ph.D., M.S.P.H.
Cancer Prevention Institute of CaliforniaMary Beth Terry, Ph.D.
Columbia University -
Consortium of Contralateral Breast Cancer (CCBC)
Since 2011
NIH Contacts
EGRP/NCI:
CCBC Liaison:
Joanne Elena, Ph.D., M.P.H.Lead Investigator:
Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center -
The Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Since 2005
NIH Contacts
EGRP/NCI:
CIMBA Liaison:
Damali Martin, Ph.D., M.P.H.Lead Investigators:
Georgia Chenevix-Trench, Ph.D.
Queensland Institute of Medical ResearchDouglas Easton, Ph.D.
University of CambridgeTimothy Rebbeck, Ph.D.
Harvard University -
Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
Since 2009
NIH Contacts
EGRP/NCI:
ENIGMA Liaison:
Melissa Rotunno, Ph.D.Lead Investigator:
David Goldgar, Ph.D.
University of Utah -
Lessons in Epidemiology and Genetics of Adult Cancer from Youth (LEGACY): a Cohort of Youth in Families from the Breast Cancer Family Registry
Since 2011
NIH Contacts
EGRP/NCI:
LEGACY Liaison:
Gabriel Lai, Ph.D.Lead Investigators:
Esther M. John, Ph.D., M.S.P.H.
Cancer Prevention Institute of CaliforniaMary Beth Terry, Ph.D.
Columbia University Medical CenterMary B. Daly, M.D., Ph.D.
Fox Chase Cancer CenterIrene L. Andrulis, Ph.D.
Samuel Lunenfeld Research Institute, Mt. Sinai HospitalSaundra Buys, M.D.
Huntsman Cancer Institute -
Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
NIH Contacts
EGRP/NCI:
PROSE Liaison:
Rao L. Divi, Ph.D.
Timothy Rebbeck, Ph.D.
Harvard University -
Women, Cancer and Radiation Exposure (WECARE)
Since 2002
NIH Contacts
EGRP/NCI:
WECARE Liaison:
Gabriel Lai, Ph.D.Lead Investigators:
Jonine Bernstein, Ph.D.
Memorial Sloan-Kettering Cancer Center
Childhood Cancers
-
Childhood Leukemia International Consortium (CLIC)
Since 2006
NIH Contacts
EGRP/NCI:
CLIC Liaison:
Somdat Mahabir, Ph.D., M.P.H.Lead Investigator:
Catherine Metayer, M.D., Ph.D.
University of California, BerkleyProject Manager:
Alice Kang
University of California, Berkley -
International Childhood Cancer Cohort Consortium (I4C)
Since 2005
NIH Contacts
EGRP/NCI:
I4C Liaison:
Somdat Mahabir, Ph.D., M.P.H.DCEG/NCI:
Martha Linet, M.D., M.P.H.Lead Investigator:
Includes various EGRP-funded investigators teamed with DCEG investigators.Terry Dwyer, A.O., M.D., M.P.H.
Murdoch Childrens Research Institute, Melbourne -
Pediatric Brain Tumor Consortium (PBTC)
Since 1999
NIH Contacts
EGRP/NCI:
PBTC Liaison:
Mukesh Verma, Ph.D.DCEG/NCI:
Peter Inskip, Sc.D.Lead Investigator:
Includes various EGRP-funded investigators teamed with DCEG investigators.
Patricia Buffler, Ph.D, M.P.H.
University of California, Berkeley
Colorectal Cancer
-
African coloRectal cancer GrOup (ARGO)
Since 2013
NIH Contacts
EGRP/NCI:
EGRP Liaison:
Krista Zanetti, Ph.D., M.P.H., R.D.Lead Investigators:
Isaac Alatise, M.D.
Obafemi Awolowo University Teaching Hospital
Ile Ife, NigeriaPeter Kingham, M.D.
Memorial Sloan Kettering Cancer Center -
Asian Colorectal Cancer Consortium (ACCC)
Since 2008
NIH Contacts
EGRP/NCI:
ACCC Liaison:
Gabriel Lai, Ph.D.Lead Investigator:
Wei Zheng, M.D., Ph.D.
Vanderbilt University School of Medicine
University of Southern California -
Colon Cancer Family Registry (C-CFR)
Since 1997
NIH Contacts
EGRP/NCI:
C-CFR Liaison:
Scott Rogers, M.P.H. (for Informatics)Lead Investigators:
Robert Haile, Dr.P.H.
Stanford UniversityNoralane (Laney) Lindor, M.D.
Mayo ClinicSteve Gallinger, M.D.
Mount Sinai Hospital
Cancer Care OntarioJohn Hopper, Ph.D.
University of MelbourneLoic Le Marchand, M.D., Ph.D.
University of Hawaii at ManoaPolly Newcomb, Ph.D., M.P.H.
Fred Hutchinson Cancer Research Center -
Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)
Since 2008
NIH Contacts
EGRP/NCI:
GECCO Liaison:
Leah Mechanic, Ph.D., M.P.H.Lead Investigator:
Ulrike Peters, Ph.D., M.P.H.
University of Washington School of Public Health -
Lynch Syndrome Screening Network (LSSN)
Since 2011
NIH Contacts
EGRP/NCI:
LSSN Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.Lead Investigators:
Debra Duquette, M.S., C.G.C.
Michigan Department of Community HealthSarah Mange, M.P.H.
Michigan Deptartment of Community HealthCecelia A. Bellcross, Ph.D., M.S., C.G.C.
Emory University School of MedicineKory Jasperson, M.S., C.G.C.
Huntsman Cancer InstituteHeather Hampel, M.S., C.G.C.
Ohio State University
Endometrial Cancer
-
Epidemiology of Endometrial Cancer Consortium (E2C2)
Since 2006
NIH Contacts
EGRP/NCI:
E2C2 Liaison:
Leah Mechanic, Ph.D., M.P.H.DCEG/NCI:
Hannah Yang, Ph.D., Sc.M.Lead Investigator:
Sara Olson, Ph.D.
Memorial Sloan-Kettering Cancer Center
Esophageal Cancer
-
Asian Barrett's Consortium
Since 2008
NIH Contacts
EGRP/NCI:
Consortium Liaison:
Gabriel Lai, Ph.D.DCEG/NCI:
Lead Investigator:
Lawrence Ho, M.B.B.S., M.D., F.R.A.C.P., F.A.M.S., F.R.C.P.
National University of Singapore -
International Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)
Since 2005
NIH Contacts
EGRP/NCI:
BEACON Liaison:
Gabriel Lai, Ph.D.DCEG/NCI:
Wong-Ho Chow, Ph.D.Lead Investigator:
Includes various EGRP-supported investigators teamed with DCEG investigators.
Thomas Vaughan, Ph.D., M.H.S.A.
Head and Neck Cancer
-
International Head and Neck Cancer Epidemiology Consortium (INHANCE)
Since 2004
NIH Contacts
DCCPS/NCI:
INHANCE Liaison:
Gabriel Lai, Ph.D.
Deborah M. Winn, Ph.D.Lead Investigators:
Mia Hashibe, M.P.H., Ph.D.
University of Utah School of Medicine
Kidney Cancer
-
International Consortium for Investigation of Inherited Renal Malignancies (I-ConFIRM)
Since 2013
NIH Contacts
EGRP/NCI:
I-ConFIRM Liaison:
Krista A. Zanetti, Ph.D., M.P.H., R.D.Lead Investigators:
Gianluca Severi, Ph.D.
Centre for Research in Epidemiology and Population Health, INSERM, Paris South UniversityEamonn Maher, B.Sc., M.D., F.R.C.P., F.Med.Sci.
University of CambridgeLoren Lipworth, Sc.D.
Vanderbilt UniversityFiona Bruinsma, Dr.P.H.
Cancer Council VictoriaIngrid Winship, M.B.Ch.B., M.D., F.R.A.C.P., F.A.C.D., F.A.I.C.D.
University of Melbourne
Leukemia
-
Childhood Leukemia International Consortium (CLIC)
Since 2006
NIH Contacts
EGRP/NCI:
CLIC Liaison:
Somdat Mahabir, Ph.D., M.P.H.Lead Investigator:
Catherine Metayer, M.D., Ph.D.
University of California, BerkleyProject Manager:
Alice Kang
University of California, Berkley -
Chronic Lymphocytic Leukemia Research Consortium (CRC)
Since 2006
NIH Contacts
Lead Investigator:
Includes various EGRP-funded investigators teamed with DCEG investigators.Thomas Kipps, Ph.D., M.D.
University of California, San DiegoManager
Andrew W. Greaves
University of California, San Diego
Liver
-
Hepatocellular Carcinoma Epidemiology Consortium (HCCEC)
Since 2011
NIH Contacts
EGRP/NCI:
HCC Liaison:
Gabriel Lai, Ph.D.Lead Investigators:
Manal M. Hassan, M.B. B.C.H., M.P.H., Ph.D.
University of Texas M.D. Anderson Cancer CenterHashem B. El-Serag, M.D., M.P.H.
Baylor College of Medicine
Lung Cancer
-
Genetic Epidemiology of Lung Cancer (GELCC)
Since 1999
NIH Contacts
EGRP/NCI:
GELCC Liaison:
Danielle Mercatante Carrick, Ph.D., M.H.S.NHGRI:
Joan Bailey-Wilson, Ph.D.Lead Investigator:
Marshall Anderson, Ph.D.
University of Cincinnati -
International Lung Cancer Consortium (ILCCO)
Since 2004
NIH Contacts
EGRP/NCI:
ILCCO Liaison:
Danielle Mercatante Carrick, Ph.D., M.H.S.DCEG/NCI:
Qing Lan, M.D., Ph.D., M.P.H.Lead Investigator:
Rayjean J. Hung, Ph.D., M.S.
Samuel Lunenfeld Research Institute
Cancer Care Ontario
Lymphoma
-
International Lymphoma Epidemiology Consortium (InterLymph)
Since 2001
NIH Contacts
EGRP/NCI:
InterLymph Liaison:
Rao Divi, Ph.D.Lead Investigators:
Sonja Berndt, Ph.D.
Senior Investigator
Division of Cancer Epidemiology and Genetics
National Cancer InstituteElizabeth Brown, Ph.D.
Professor
Department of Pathology
University of Alabama, BirminghamJames McKay, Ph.D.
Group Head
Genetic Cancer Susceptibility Group
International Agency for Research on Cancer
Ovarian Cancer
-
Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium (ENIGMA)
Since 2009
NIH Contacts
EGRP/NCI:
ENIGMA Liaison:
Melissa Rotunno, Ph.D.Lead Investigator:
David Goldgar, Ph.D.
University of Utah -
Ovarian Cancer Association Consortium (OCAC)
Since 2005
NIH Contacts
EGRP/NCI:
OCAC Liaison:
Lisa Gallicchio, Ph.D.
Stefanie Nelson, Ph.D.Lead Investigator:
Andrew Berchuck, M.D.
Duke University Comprehensive Cancer Center -
Ovarian Cancer Cohort Consortium (OC3)
Since 2009
NIH Contacts
EGRP/NCI:
OC3 Liaison:
Lisa Gallicchio, Ph.D.
Stefanie Nelson, Ph.D.DCEG/NCI:
Nicolas Wentzensen, M.D., Ph.D.Lead Investigators:
Shelley Tworoger, Ph.D.
Harvard University School of Public HealthAlan Arslan, M.D.
New York University -
Ovarian Cancer in Women of African Ancestry (OCWAA)
-
Pacific Ovarian Cancer Research Consortium (POCRC)
Since 1999
NIH Contacts
EGRP/NCI:
POCRC Liaison:
Tram Kim Lam, Ph.D., M.P.H.Lead Investigator:
Nicole Urban, Ph.D.
University of Washington School of Public Health -
Prevention and Observation of Surgical Endpoints and Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (PROSE-Modifiers Studies) (Collaborative Studies of BRCA 1/2 Mutation Carriers)
NIH Contacts
EGRP/NCI:
PROSE Liaison:
Rao L. Divi, Ph.D.
Timothy Rebbeck, Ph.D.
Harvard University
Pancreatic Cancer
-
Pancreatic Cancer Case Control Consortium (PANC4)
NIH Contacts
EGRP/NCI:
PANC4 Liaison:
Gabriel Lai, Ph.D.Lead Investigator:
Gloria Petersen, Ph.D.
Mayo Clinic -
Pancreatic Cancer Cohort Consortium
Since 2006
NIH Contacts
EGRP/NCI:
PanScan Liaison:
Joanne Watters Elena, Ph.D., M.P.H.DCEG/NCI:
Laufey Amundadottir, Ph.D.Lead Investigator:
Charles Fuchs, M.D., M.P.H.
Harvard University -
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)
Since 2002
NIH Contacts
EGRP/NCI:
PACGENE Liaison:
Gabriel Lai, Ph.D.Lead Investigator:
Gloria Petersen, Ph.D.
Mayo Clinic
Prostate Cancer
-
Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in BRCA1 and BRCA2 mutation carriers and controls (IMPACT)
Since 2005
NIH Contacts
EGRP/NCI:
IMPACT Liaison:
Rao L. Divi, Ph.D.Lead Investigator:
Rosalind Eeles, Ph.D.
The Institute of Cancer Research, UK -
International Consortium on Prostate Cancer Genetics (ICPCG)
Since 1996
NIH Contacts
EGRP/NCI:
ICPCG Liaison:
Danielle Daee, Ph.D.NHGRI:
Joan Bailey-Wilson, Ph.D.Lead Investigator:
Includes various EGRP-funded investigators teamed with NHGRI investigators.Stephen N. Thibodeau, Ph.D.
Mayo Clinic -
Men of African Descent and Prostate Cancer (MADCaP)
Since 2007
NIH Contacts
EGRP/NCI:
MADCaP Liaison:
Damali Martin, Ph.D., M.P.H.DCEG/NCI:
Anne Hsing, Ph.D.Lead Investigator:
Timothy Rebbeck, Ph.D.
Harvard University -
Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL)
Since 2007
NIH Contacts
EGRP/NCI:
PRACTICAL Liaison:
Danielle Daee, Ph.D.Lead Investigators:
Rosalind Eeles, Ph.D.
The Institute of Cancer Research, UKZsofia Kote-Jarai, Ph.D.
The Institute of Cancer Research, UKDouglas Easton, Ph.D.
University of Cambridge and Cancer Research UKSara Benlloch Garcia (Coordinator)
University of Cambridge -
Prostate Cancer Transatlantic Consortium (CaPTC)
Since 2005
NIH Contacts
EGRP/NCI:
CaPTC Liaison:
Damali Martin, Ph.D., M.P.H.Lead Investigator:
Folakemi T. Odedina, Ph.D.
University of Florida College of Pharmacy and Shands Cancer Center
Skin Cancers
-
Keratinocyte Carcinoma Consortium (KeraCon)
Since 2014
NIH Contacts
EGRP/NCI:
KeraCon Liaison:
Gabriel Lai, Ph.D.Lead Investigators:
Martin Weinstock, M.D., Ph.D.
Brown UniversityLeah Ferrucci, Ph.D., M.P.H.
Yale School of Public Health -
Melanoma Genetics Consortium (GenoMEL)
Since 1997
NIH Contacts
EGRP/NCI:
GenoMEL Liaison:
Danielle Mercatante Carrick, Ph.D., M.H.S.DCEG/NCI:
Alisa Goldstein, Ph.D.Lead Investigators:
Peter Kanetsky
Moffitt Cancer CenterJulia Newton-Bishop, M.D.
Leeds Cancer Centre at St James's University Hospital, England
Testicular Cancer
-
Testicular Cancer Consortium (TECAC)
Since 2012
NIH Contacts
EGRP/NCI:
TECAC Liaison:
Krista A. Zanetti, Ph.D., M.P.H., R.D.Lead Investigator:
Stephen M. Schwartz, Ph.D.
Fred Hutchinson Cancer Research Center
Multiple Cancers
-
African-Caribbean Cancer Consortium (AC3)
Since 2006
NIH Contacts
EGRP/NCI:
AC3 Liaison:
TBDLead Investigator:
Camille Ragin Ph.D., M.P.H.
Fox Chase Cancer Center -
Asia Cohort Consortium
Since 2004
NIH Contacts
Lead Investigators:
John Potter M.D. Ph.D.
Fred Hutchinson Cancer Research CenterDaehee Kang, M.D., Ph.D.
Seoul National University College of Medicine, Korea -
Cancer Genetics Network (CGN)
Since 1998
NIH Contacts
EGRP/NCI:
CGN Liaison:
Scott Rogers, M.P.H.Lead Investigator:
Dianne L. Finkelstein, Ph.D.
Massachusetts General Hospital -
Clinical Cancer Genetics Community Research Network (CCGCRN)
Since 2014
NIH Contacts
EGRP/NCI:
CCGCRN Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.Lead Investigator:
Jeff Weitzel, M.D.
City of HopeResearch Administrator:
Sharon Sand, C.C.R.P.
City of Hope -
Comprehensive Oncologic Emergencies Research Network (CONCERN)
Since 2015
NIH Contacts
EGRP/NCI:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.NIGMS:
Jeremy Brown, M.D.Lead Investigators:
Jeff Caterino, M.D.
The Ohio State UniversityCorita Grudzen, M.D.
NYU Langone Medical CenterDemetrious (Jim) Kyriacou, M.D., Ph.D.
Northwestern University -
Latin American Cancer Epidemiology Consortium (LACE)
Since 2008
NIH Contacts
EGRP/NCI:
LACE Liaison:
Tram Kim Lam, Ph.D., M.P.H.NCI/OD
Jorge Gomez, M.D., Ph.D.
Office of Latin American Cancer Program DevelopmentLead Investigators:
Robert Haile, Dr.P.H.
Stanford University -
Li-Fraumeni Exploration Consortium (LiFE)
Since 2010
NIH Contacts
EGRP/NCI:
LiFE Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.DCEG/NCI:
Sharon Savage, M.D.Lead Investigators:
David Malkin, M.D.
University of TorontoJudy Garber, M.D., M.P.H.
Dana-Farber Cancer InstituteLouise Strong, M.D.
The University of Texas M.D. Anderson Cancer CenterPierre Hainaut, Ph.D.
International Agency for Research on CancerMaria Isabel Achatz, M.D., Ph.D.
Hospital A.C. Carmargo-Fundação Antonio Prudente, São Paulo, Brazil -
NCI Cohort Consortium
Since 2000
NIH Contacts
EGRP/NCI:
NCI Cohort Consortium Liaison:
Nonye Harvey, M.P.H.DCEG/NCI:
Robert Hoover, M.D., Sc.D.Lead Investigators:
Elio Riboli, M.D., M.P.H., M.Sc. (Chair)
Imperial CollegeLeslie Bernstein, Ph.D.
City of Hope National Medical Center and Beckman Research InstituteWilliam J. Blot, Ph.D.
Vanderbilt University and International Epidemiology Institute, Ltd.Susan Gapstur, Ph.D., M.P.H.
American Cancer Society, Inc.Mattias Johansson, Ph.D.
International Agency for Research on Cancer (IARC/WHO)Meir Stampfer, M.D, Dr. P.H.
Harvard Medical School, Harvard School of Public Health, and Brigham and Women's HospitalAnthony Swerdlow, Ph.D., M.P.H.
University of London, Institute of Cancer ResearchWei Zheng, M.D., Ph.D., M.P.H.
Vanderbilt University Medical Center -
Radiogenomics Consortium (RGC)
Since 2009
NIH Contacts
EGRP/NCI:
Radiogenomics Consortium Liaison:
Nonniekaye Shelburne, C.R.N.P., M.S., A.O.C.N.DCEG/NCI:
Alice Sigurdson, Ph.D.Lead Investigators:
Barry Rosenstein, Ph.D.
Mount Sinai School of MedicineCatharine West, Ph.D.
University of Manchester School of Medicine
- EGRP - Epidemiology and Genomics Research Program
- CDC - Centers for Disease Control and Prevention
- DCB - Division of Cancer Biology
- DCEG - Division of Cancer Epidemiology and Genetics
- NCI - National Cancer Institute
- NHGRI - National Human Genome Research Institute
- NIEHS - National Institute of Environmental Health Sciences
- NIGMS - National Institute of General Medical Sciences
- NIH - National Institutes of Health
- OCS - Office of Cancer Survivorship
- OD - Office of the Director
Additional Research Consortia
A number of additional research consortia conduct research to better understand determinants of various health outcomes in human populations, which may influence cancer risk. Some of the collaborations in which EGRP staff participate include:
- COnsortium of METabolomics Studies (COMETS)
- Dietary Patterns Methods Project (DPMP)
- Metabolomics Quality Assurance and Quality Control Consortium (mQACC)
- Multi-cohort Eating and Activity Study for Understanding Reporting Error (MEASURE)
- Obesity Policy Research Grantees Network
- Sensor Methods Collaboratory
- Validation Studies Pooling Project (VSPP)
Role of EGRP in Consortia
EGRP fosters consortia through the following activities:
- Advising investigators on the formation of new consortia
- Advising consortia on policies and processes related to funding, data sharing, and collaborations
- As appropriate, participating on steering or executive committees or working groups.
Questions about EGRP and Consortia can be sent to NCIEpiCommunications@mail.nih.gov.
Data Sharing Expectations for Consortia
EGRP supports compliance with the NIH Data Sharing Policy and Genomic Data Sharing Policy. Data sharing is essential for expedited translation of research results into knowledge, products, and procedures to improve human health. To help investigators comply with these policies, NCI and NIH support a number of data repositories to help facilitate efficient data sharing, including the database of Genotypes and Phenotypes (dbGaP).